Amazon Healthcare Message Board

Amazon Creates Healthcare Company to Lower Healthcare Costs

1 year ago

Because they are looking to turn healthcare upside down. Look to add healthcare to your prime membership in the future.

How Amazon is attacking Healthcare

1 year ago

This is great presentation created by CB Insights analyst, Nikhil Kirshnan, (@nikillinit) that reviews how Amazon could be attacking the healthcare industry. Enjoy and share your thoughts!

Amazon is entering the medical supply business

2 years ago

Amazon has consistently proved doubters wrong in EVERY single industry they've entered so it's hard for me to say they can't be successful. However, what do you mean that they can make the supply chain more efficient? I don't envision Amazon handling anything with manufacturing. They are more likely to leverage better contracting between hospitals and device companies. Even that sounds weird...why can't medical device companies do a better job at this?

Most important to me, what happens to the re…

Amazon Enters Pharmacy Business with PillPack Acquisition

2 years ago

Amazon and Bezos are so smart -

In November, those same analysts wrote, "We note too that the older demographic still under-indexes toward Prime membership...which speaks to the opportunity for Pharma to help Amazon further penetrate the ~80 million 55 population in the United States."

Morgan Stanley's research shows Amazon Prime has the lowest penetration in the demographic of customers over 55. The average American over the age of 65 has around 37 prescriptions per year, the report estimated. …

Amazon Basic Care and Perrigo

2 years ago

Amazon also lowered their Prime membership from 12.99 per month to $5.99 for Medicare patients. This helps Amazon get access to older people who would like the convenience of shopping for their medicine online.

I have a feeling Amazon is on its way to becoming the Home Shopping Network for old people.

Amarin gets boost from AstraZeneca and Acasti's study failures

6 days ago

After fake news attacks, and constant attacks by short sellers, Amarin investors finally woke up to some great news on Monday morning as AstraZeneca​ and Acasti Pharma​​ both announced surprisingly disappointing study results for their fish oil products